At Cornerstone Therapeutics, our strategy is to:
- Focus our commercial and internal development efforts in the hospital and related specialty sector within the U.S. pharmaceutical marketplace;
- Acquire companies and marketed and/or registration-stage products that fit within our focus areas; and
- Market approved generic products through our wholly-owned subsidiary, Aristos.
Cornerstone Therapeutics is actively seeking to acquire, in-license, and distribute proprietary products that fit this strategy. You may contact us at firstname.lastname@example.org.